Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on Phase 1/2 results of a radiolabeled monoclonal antibody therapy for primary brain tumors; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors

Drugs mentioned

• Radiolabeled Monoclonal Antibody Therapy

Snippet

Sponsor: Duke University | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED